Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-16-042926
Filing Date
2016-12-08
Accepted
2016-12-08 19:19:42
Documents
1
Period of Report
2016-12-06

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 3798
  Complete submission text file 0001225208-16-042926.txt   5102
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Washington A. Eugene (Reporting) CIK: 0001561989 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03215 | Film No.: 162042573